Theriva Biologics, Inc. Equity Method Investment, Ownership Percentage
Theriva Biologics, Inc. (TOVX) had Equity Method Investment, Ownership Percentage of 83.00% as of 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-03-16
- 2021-12-31: Equity Method Investment, Ownership Percentage 83.00%.
- 2020-12-31: Equity Method Investment, Ownership Percentage 83.00%.
- 2019-12-31: Equity Method Investment, Ownership Percentage 83.00%.
- 2018-12-31: Equity Method Investment, Ownership Percentage 83.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2021-12-31 | 83.00% 10-K · filed 2022-03-16 |
| 2020-12-31 | 83.00% 10-K · filed 2021-03-04 |
| 2019-12-31 | 83.00% 10-K · filed 2020-02-20 |
| 2018-12-31 | 83.00% 10-K · filed 2019-02-27 |
| 2018-09-30 | 88.50% 10-Q · filed 2018-11-08 |
| 2018-06-30 | 88.50% 10-Q · filed 2018-08-08 |
| 2018-03-31 | 88.50% 10-Q · filed 2018-05-08 |
| 2017-12-31 | 88.50% 10-K · filed 2018-02-22 |
| 2017-09-30 | 88.50% 10-Q · filed 2017-11-01 |
| 2017-06-30 | 88.50% 10-Q · filed 2017-08-03 |
| 2017-03-31 | 88.50% 10-Q · filed 2017-05-04 |
| 2016-12-31 | 88.50% 10-K · filed 2018-02-22 |
| 2015-12-31 | 88.50% 10-K · filed 2016-03-10 |
| 2015-09-30 | 88.50% 10-Q · filed 2015-11-05 |
| 2014-12-31 | 80.00% 10-K · filed 2015-03-16 |
| 2013-12-31 | 80.00% 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |